302 related articles for article (PubMed ID: 15527675)
21. Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period.
Terada T; Matsunaga Y; Maeta H; Endo K; Horie S; Ohta T
Virchows Arch; 1999 Dec; 435(6):606-11. PubMed ID: 10628803
[TBL] [Abstract][Full Text] [Related]
22. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.
Norton JA; Jensen RT
Ann Surg; 2004 Nov; 240(5):757-73. PubMed ID: 15492556
[TBL] [Abstract][Full Text] [Related]
23. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R
Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
[TBL] [Abstract][Full Text] [Related]
25. Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature.
Roy PK; Venzon DJ; Feigenbaum KM; Koviack PD; Bashir S; Ojeaburu JV; Gibril F; Jensen RT
Medicine (Baltimore); 2001 May; 80(3):189-222. PubMed ID: 11388095
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
[TBL] [Abstract][Full Text] [Related]
27. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy of Zollinger-Ellison syndrome.
Ito T; Igarashi H; Uehara H; Jensen RT
Expert Opin Pharmacother; 2013 Feb; 14(3):307-21. PubMed ID: 23363383
[TBL] [Abstract][Full Text] [Related]
30. [Recent trend of diagnosis and treatment for Zollinger-Ellison syndrome].
Imamura M; Komoto I; Doi R
Gan To Kagaku Ryoho; 2005 Feb; 32(2):147-51. PubMed ID: 15751623
[TBL] [Abstract][Full Text] [Related]
31. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.
Hoffmann KM; Gibril F; Entsuah LK; Serrano J; Jensen RT
J Clin Endocrinol Metab; 2006 Jan; 91(1):204-12. PubMed ID: 16249283
[TBL] [Abstract][Full Text] [Related]
32. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
33. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.
Norton JA; Doppman JL; Jensen RT
Ann Surg; 1992 Jan; 215(1):8-18. PubMed ID: 1531004
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.
Ito T; Cadiot G; Jensen RT
World J Gastroenterol; 2012 Oct; 18(39):5495-503. PubMed ID: 23112541
[TBL] [Abstract][Full Text] [Related]
35. Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).
Norton JA; Jensen RT
Surg Oncol; 2003 Aug; 12(2):145-51. PubMed ID: 12946485
[TBL] [Abstract][Full Text] [Related]
36. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
37. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
38. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
Kanakis G; Kaltsas G
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
[TBL] [Abstract][Full Text] [Related]
39. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C
Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627
[TBL] [Abstract][Full Text] [Related]
40. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
Jensen RT; Fraker DL
JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
